inz-701
inz-701: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Inozyme Pharma, Inc. (INZY) | Phase 3 |
Clinical Trials (1)
The ENERGY Study: An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infants With Ectonucleotide Pyrophosphatase/ Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency
Frequently asked questions
Who is developing inz-701?
inz-701 is being developed by Inozyme Pharma, Inc..
How many clinical trials involve inz-701?
BioSniper tracks 1 clinical trial involving inz-701.
Get deeper analysis on inz-701
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis